Cytokine and chemokine network

The cytokine and chemokine network is a complex, integrated system of small signaling proteins and their cognate receptors that coordinate the immune response and maintain physiological homeostasis [1, 2]. Cytokines, including interleukins, interferons, and tumor necrosis factors, act as primary messengers that regulate cell growth, differentiation, and activation, while chemokines specifically direct the migration (chemotaxis) of immune cells to sites of inflammation or injury [2, 4]. This network is characterized by high levels of pleiotropy, where one molecule has multiple effects, and redundancy, where multiple molecules perform similar functions, making it a robust but difficult system to modulate [1, 3]. Dysregulation of this network—either through overproduction of pro-inflammatory mediators or deficiency in anti-inflammatory signals—is central to the pathogenesis of autoimmune diseases like rheumatoid arthritis, chronic inflammatory conditions, and life-threatening systemic inflammatory responses [3, 5]. Therapeutic strategies targeting this network have revolutionized medicine and include monoclonal antibodies that neutralize specific ligands, receptor antagonists, and small-molecule inhibitors of downstream signaling pathways like the JAK-STAT cascade [3, 5].

Other names

Cytokine signaling pathwayChemokine signaling pathwayInflammatory mediator networkCytokine-chemokine axis

Drugs targeting this network function through various mechanisms, including the direct neutralization of circulating cytokine ligands using monoclonal antibodies or soluble receptors, the competitive blockade of cell-surface receptors to prevent ligand binding, and the inhibition of intracellular signaling transducers, such as Janus kinases (JAKs), which are essential for signal propagation from cytokine receptors to the nucleus [3, 5].